Purpose
Focus Area
01
Incidence of diabetes mellitus among family members of type-2 diabetic patients registered in Seremban- Prospective cohort study (SeDia Cohort Study)
02
Clinical prediction tool for diabetic nephropathy among type-2 diabetes patients
03
Clinical studies to assess the effectiveness of drugs used in primary care medicine
Core Facilities
- Statistical package for social sciences and STATA/MP version 18.5
- Clinical trials unit
Strategic Plan
The need for clinical research was witnessed during the most recent period of 2000-2022 the two years of the pandemic which saw millions of publications about Covid19 which has an array of impacts due to the global shutdown. The clinical research from clinical case series analyses to clinical trials of all phases was witnessed leading to the discovery of Covid19 vaccine and rapid investigations into its effectiveness. The challenge of its implementation also went through a series of epidemiological research testing its effectiveness and acceptance at the community level. The scientific community contributed immensely to showcasing the demand for researchers in clinical epidemiology. The future practice of clinical medicine and public health underscores the skills needed to provide expedited evidence to tackle the current and future burden of disease and the possible emergence of a new pandemic.
The following strategic plans are proposed for the 5-year period 2023 to 2028.
Vision
Improving population health through the application of biomedical research in clinical practice.
Mission
To provide research resources, training, and collaboration opportunities for IMU staff, Industry healthcare providers, and the public
Strategic Objectives and Organisation Goals
Financial
- Increase additional funding by at least 50% for CTR
- Apply for additional grants
- Industry partnership for clinical trials
- Organize courses and congresses
Core Values
- Research integrity
- Community service
- Professionalism
- Research Excellence
- Research capacity building
Customer
- Provide baseline assessment and follow-up visits to at least 90% of patients registered in the Diabetes Register
- Provide a clinical trial implementation platform to the Pharma industry and the ministry of health
- Provide training to ministry and pharma staff in clinical epidemiology and trial management
Strategies
- 2023-24 Recruit staff and 2024- establish trials unit
- 2025-26- apply additional funds, generate revenue, and initiate training in clinical epidemiology and advanced biostatistics
- 2027-28- preliminary analyses, Report on Cohort profile
People and Learning
- To provide a research platform to train IMU staff and students in clinical research
- To engage IMU staff and students in community services
- To improve the uptake of diabetes screening, treatment adherence in the community
Services Offered
Expertise / Team
Centre Head
Prof Dr Chandrashekhar Thummala Hally Sreerama Reddy
Professor, Department of Community Medicine,
School of Medicine
